🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Dimerix Ltd (DXB)

Sydney
Currency in AUD
Disclaimer
0.380
0.000(0.00%)
Closed
DXB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.3700.380
52 wk Range
0.1250.665
Bid/Ask
0.37 / 0.38
Prev. Close
0.38
Open
0.38
Day's Range
0.37-0.38
52 wk Range
0.125-0.665
Volume
658,019
Average Volume (3m)
3,071,695
1-Year Change
514.75%
Fair Value
Unlock
Fair Value Upside
Unlock
DXB Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year
Show more

Dimerix Ltd Company Profile

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. The company develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 which is in phase 2 clinical trial for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. Dimerix Limited is headquartered in Fitzroy, Australia.

Compare DXB to Peers and Sector

Metrics to compare
DXB
Peers
Sector
Relationship
P/E Ratio
−12.4x−3.2x−0.6x
PEG Ratio
−1.120.010.00
Price/Book
11.6x2.5x2.6x
Price / LTM Sales
362.8x12.7x3.2x
Upside (Analyst Target)
121.1%210.0%48.4%
Fair Value Upside
Unlock13.3%6.8%Unlock

FAQ

What Is the Dimerix (DXB) Stock Price Today?

The Dimerix stock price today is 0.38

What Stock Exchange Does Dimerix Trade On?

Dimerix is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for Dimerix?

The stock symbol for Dimerix is "DXB."

What Is the Dimerix Market Cap?

As of today, Dimerix market cap is 211.67M.

What is Dimerix Earnings Per Share?

The Dimerix EPS is -0.038.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.